InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by McCarthy Christopher. Director active across 1 company, notably Interpace Biosciences, INC.. In total, 3 reports have been published. Activity tracked since 31 July 2023. The latest transaction was filed on 31 July 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations